![]() |
Understanding the Stages of Breast Cancer
|
![]() |
The Pros and Cons of Breast Cancer Adjuvant Therapy
|
![]() |
Using Aromatase Inhibitors in Early Stage Breast Cancer
|
![]() |
Breast Cancer Genetics
|
![]() |
Hormonal Therapy for Breast Cancer: Assessing Benefits and Side Effects
|
![]() |
Breast Cancer: What is Your Risk?
|
![]() |
How to Succeed With Breast Cancer Adjuvant Therapy
|
![]() |
A Good Doctor-Patient Relationship in Breast Cancer
|
![]() |
Anthracyclines in Adjuvant Breast Cancer Therapy: Survival Benefits
|
![]() |
Hormonal Therapy for Breast Cancer: New Options
|
![]() |
New Technologies in Breast Cancer: Breast Ultrasound
|
![]() |
What is Hormone Receptor Positive Breast Cancer?
|
![]() |
Anthracyclines for Breast Cancer: Does Stage Matter?
|
![]() |
Bone Complications in Breast Cancer
|
![]() |
Interpreting Mammograms
|
![]() |
Which Adjuvant Therapy is Right for Your Breast Cancer?
|
![]() |
Preventing Breast Cancer Recurrence: What's Right for Me?
|
![]() |
Technologies in Breast Cancer: Breast MRI
|
![]() |
Breast Cancer Trials: How Have They Changed Breast Cancer Therapy?
|
![]() |
Advice To Women Newly Diagnosed With Breast Cancer
|
![]() |
Technologies in Breast Cancer: Digital Mammography
|
![]() |
A New Voice in Breast Cancer Activism: Soraya's Story
|
![]() |
Breast Cancer Detection
|
![]() |
Better Breast Cancer Therapy: Making Anthracyclines More Effective
|
![]() |
Hormone Replacement Therapy vs. Hormonal Treatment: What's the Difference?
|
![]() |
Living with Breast Cancer Treatments: Personal Stories
|
![]() |
Preparing For Side Effects: What to Expect From Breast Cancer Therapies
|
![]() |
Technologies in Breast Cancer: Positron Emission Tomography
|
![]() |
Understanding Hormonal Therapy for Early Stage Breast Cancer
|
![]() |
Hormonal Therapy for Breast Cancer: Current Issues
|
![]() |
Talking to Your Doctor About Early-Stage Breast Cancer
|
Breast cancer is caused by the development of malignant cells in the breast. The malignant cells originate in the lining of the milk glands or ducts of the breast (ductal epithelium), defining this malignancy as a cancer. Cancer cells are characterized by uncontrolled division leading to abnormal growth and the ability of these cells to invade normal tissue locally or to spread throughout the body, in a process called metastasis.
Breast cancer arises in the milk-producing glands of the breast tissue. Groups of glands in normal breast tissue
The primary tumor begins in the breast itself but once it becomes invasive, it may progress beyond the breast to the regional lymph nodes or travel (metastasize) to other organ systems in the body and become systemic in nature. Lymph is the clear, protein-rich fluid that bathes the cells throughout the body. Lymph will work its way back to the bloodstream via small channels known as lymphatics. Along the way, the lymph is filtered through cellular stations known as nodes, thus they are called lymph nodes. Nearly all organs in the body have a primary lymph node group filtering the tissue fluid, or lymph, that comes from that organ. In the breast, the primary lymph nodes are under the armpit, or axilla. Classically, the primary tumor begins in the breast and the first place to which it is likely to spread is the regional lymph nodes. Cancer, as it invades in its place of origin, may also work its way into blood vessels. If cancer gets into the blood vessels, the blood vessels provide yet another route for the cancer to spread to other organs of the body.
Breast cancer follows this classic progression though it often becomes systemic or widespread early in the course of the disease. By the time one can feel a lump in the breast it is often 0.4 inches, or one centimeter, in size and contains roughly a million cells. It is estimated that a tumor of this size may take one to five years to develop. During that time, the cancer may metastasize, or spread by lymphatics or blood to areas elsewhere in the body.
When primary breast cancer spreads, it may first go to the regional lymph nodes under the armpit, the axillary nodes. If this occurs, regional metastasis exists. If it proceeds elsewhere either by lymphatic or blood-borne spread, the patient develops systemic metastasis that may involve a number of other organs in the body. Common sites of systemic involvement for breast cancer are the lung, bones, liver, and the skin and soft tissue. As it turns out, the presence of, and the actual number of, regional lymph nodes containing cancer remains the single best indicator of whether or not the cancer has become widely metastatic. Because tests to discover metastasis in other organs may not be sensitive enough to reveal minute deposits, the evaluation of the axilla for regional metastasis becomes very important in making treatment decisions for this disease.
If breast cancer spreads to other major organs of the body, its presence will compromise the function of those organs. Death is the result of extreme compromise of vital organ function.
|
|
Author Info: Richard A. McCartney M.D., Carol A. Turkington, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Cancer, 2002 |